SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Ninalga Christina)
 

Search: WFRF:(Ninalga Christina) > Optimization of the...

Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy

Loskog, Angelica, 1973- (author)
Uppsala universitet,Enheten för klinisk immunologi
Ninalga, Christina (author)
Uppsala universitet,Enheten för klinisk immunologi
Hedlund, Titti (author)
Uppsala universitet,Enheten för klinisk immunologi
show more...
Alimohammadi, Mohammad (author)
Division of Molecular Medicine, Uppsala University Hospital
Malmström, Per-Uno (author)
Uppsala universitet,Institutionen för kirurgiska vetenskaper,Experimental Urology
Tötterman, Thomas H. (author)
Uppsala universitet,Enheten för klinisk immunologi
show less...
 (creator_code:org_t)
2016-06-24
2005
English.
In: Laboratory Animals. - : SAGE Publications. - 0023-6772 .- 1758-1117. ; 39:4, s. 384-393
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Bladder cancer is regarded as a promising candidate for innovative therapies in the field of immune and gene therapy. In this paper, we present the subcutaneous, metastatic and a novel orthotopic model of murine MB49 bladder cancer in C57BL/6 mice. We further show the potential of using adenoviral vectors together with different transduction enhancers to augment in vivo gene delivery. Finally, we present candidate genes for tumour detection, therapy or targeting. The MB49 tumour grew rapidly in mice. The subcutaneous model allowed for tumour detection within a week and the possibility to monitor growth rate on a day-by-day basis. Injection of MB49 cells intravenously into the tail vein gave rise to lung metastases within 16 days, while instillation of tumour cells into pretreated bladders led to a survival time of 20-40 days. Adenoviral vectors can be used as a vehicle for gene transfer to the bladder. By far, the most potent transduction enhancer was Clorpactin, also known as oxychlorosene. Last, we show that MB49 cells express tumour-associated antigens like bladder cancer-4, prostate stem cell antigen and six-transmembrane epithelial antigen of the prostate. Given the possibility for efficient genetic modification of the bladder and the presence of known tumour antigens, the MB49 models can be used in innovative ways to explore immunogene therapy.

Keyword

Adenoviridae/genetics
Animals
Antigens; Neoplasm/biosynthesis/genetics
Benzenesulfonates/pharmacology
Bladder Neoplasms/genetics/metabolism/pathology/*therapy
Blotting; Western
Cell Line; Tumor
Female
Gene Therapy/*methods
Genetic Vectors
H-Y Antigen/biosynthesis/genetics
Lung Neoplasms/secondary
Male
Mice
Mice; Inbred C57BL
RNA; Neoplasm/chemistry/genetics
Research Support; Non-U.S. Gov't
Reverse Transcriptase Polymerase Chain Reaction
Specific Pathogen-Free Organisms
Transduction; Genetic/methods
Tumor Markers; Biological/metabolism
MEDICINE
MEDICIN

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view